parturient with full-term pregnancy and analgesic requirement
Conditions
Interventions
Group B:0.067% ropivacaine + 0.33 µg/mL sufentanil + 0.2 µg/mL dexmedetomidine.
Group A:0.067% ropivacaine + 0.33 µg/mL sufentanil
Sponsors
guang yuan central hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1.Nulliparous women aged between 18 and 40 years; 2.Singleton pregnancy, gestational age over 37 weeks; 3.No pregnancy complications (such as gestational hypertension, diabetes, etc.); 4.No history of drug allergies or contraindications; 5.Voluntarily participating in this study and signing the informed consent form;
Exclusion criteria
Exclusion criteria: 1.Have neurological diseases or mental disorders; 2.Multiparous women and multiple pregnancies; 3.Contraindications for epidural anesthesia (such as coagulopathy, infection, etc.); 4.History of opioid or dexmedetomidine abuse; 5.Patients with height less than 145 or BMI greater than 35; 6.Those unable to cooperate in completing the research procedure;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Labor Analgesia Success Rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| Degree of Lower Limb Motor Block;Number of PCA Boluses;Labor Analgesia-Related Adverse Events;Neonatal Arterial Blood Gas (ABG); | — |
Countries
China
Contacts
Public ContactMabin
guang yuan central hospital
Outcome results
None listed